- Release Date: 08/04/21 08:32
- Summary: Exopharm Shareholder Update - Revenue Focus in 2021
- Price Sensitive: No
- Download Document 230.74KB
Ann: Exopharm Shareholder Update - Revenue Focus in 2021
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EX1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.833M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EX1 (ASX) Chart |
Day chart unavailable